HK Stock MarketDetailed Quotes
02269 WUXI BIO
- 18.560
- +0.660+3.69%
Noon Break Oct 10 11:59 CST
77.11BMarket Cap26.74P/E (TTM)
18.800High17.780Low61.96MVolume18.400Open17.900Pre Close1.14BTurnover1.49%Turnover Ratio20.55P/E (Static)4.15BShares52.45052wk High1.73P/B77.11BFloat Cap10.14052wk Low--Dividend TTM4.15BShs Float148.000Historical High--Dividend LFY5.70%Amplitude8.333Historical Low18.345Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
WUXI BIO Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -22.10%4.17B | ---- | 34.18%5.36B | ---- | 103.13%3.99B | ---- | 74.48%1.97B | ---- | 52.72%1.13B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -103.93%-219.18M | ---- | -85.22%-107.48M | ---- | 28.24%-58.03M | ---- | -26.63%-80.86M | ---- | 18.54%-63.86M |
| Dividend (income)- adjustment | ---- | ---- | ---- | ---8.32M | ---- | ---- | ---- | ---- | ---- | ---- |
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---14.05M |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -184.39%-2.63M | ---- | --3.12M |
| Impairment and provisions: | ---- | 8.84%319M | ---- | -37.34%293.09M | ---- | 1,334.40%467.72M | ---- | 152.12%32.61M | ---- | 98.48%12.93M |
| -Impairmen of inventory (reversal) | ---- | 3,201.95%72.91M | ---- | -99.00%2.21M | ---- | 1,040.38%220.56M | ---- | 443.13%19.34M | ---- | -11.88%3.56M |
| -Impairment of trade receivables (reversal) | ---- | 31.97%318.98M | ---- | 57.00%241.71M | ---- | --153.96M | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | -248.21%-72.89M | ---- | -47.23%49.18M | ---- | 602.55%93.2M | ---- | 41.55%13.27M | ---- | 278.67%9.37M |
| Revaluation surplus: | ---- | 108.22%27.23M | ---- | 52.53%-331.39M | ---- | -87.93%-698.03M | ---- | -2,310.21%-371.44M | ---- | -37.97%-15.41M |
| -Derivative financial instruments fair value (increase) | ---- | -14.52%41.07M | ---- | 247.41%48.05M | ---- | ---32.59M | ---- | ---- | ---- | ---- |
| -Other fair value changes | ---- | 96.35%-13.83M | ---- | 42.98%-379.44M | ---- | -79.15%-665.44M | ---- | -2,310.21%-371.44M | ---- | -37.97%-15.41M |
| Asset sale loss (gain): | ---- | -81.92%3.48M | ---- | 2,115.29%19.27M | ---- | -67.29%870K | ---- | 85.11%2.66M | ---- | 18.27%1.44M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -81.92%3.48M | ---- | 2,115.29%19.27M | ---- | -67.29%870K | ---- | 85.11%2.66M | ---- | 18.27%1.44M |
| Depreciation and amortization: | ---- | 46.05%1.17B | ---- | 66.19%800.67M | ---- | 58.50%481.78M | ---- | 35.47%303.96M | ---- | 53.81%224.38M |
| -Amortization of intangible assets | ---- | 7.01%61.07M | ---- | 19.71%57.07M | ---- | 48.74%47.67M | ---- | 53.98%32.05M | ---- | 108.79%20.81M |
| -Other depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -68.43%951K | ---- | -30.77%3.01M |
| Financial expense | ---- | 146.17%158.49M | ---- | 64.28%64.38M | ---- | -8.29%39.19M | ---- | 117.96%42.73M | ---- | --19.61M |
| Exchange Loss (gain) | ---- | -181.49%-537.47M | ---- | -1,649.96%-190.94M | ---- | -80.54%12.32M | ---- | 589.15%63.31M | ---- | 151.80%9.19M |
| Special items | ---- | 3.91%1.25B | ---- | 138.26%1.2B | ---- | 30.83%505.63M | ---- | 92.62%386.48M | ---- | -27.15%200.64M |
| Operating profit before the change of operating capital | ---- | -10.63%6.35B | ---- | 49.68%7.1B | ---- | 102.54%4.74B | ---- | 55.69%2.34B | ---- | 42.02%1.5B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 188.83%442.46M | ---- | 36.40%-498.12M | ---- | -11.17%-783.19M | ---- | -649.45%-704.52M | ---- | 1.75%-94.01M |
| Accounts receivable (increase)decrease | ---- | 8.24%-1.03B | ---- | 15.55%-1.12B | ---- | 6.24%-1.33B | ---- | -120.28%-1.42B | ---- | -42.28%-643.86M |
| Accounts payable increase (decrease) | ---- | 68.11%-162.34M | ---- | -168.62%-509.02M | ---- | -0.71%741.85M | ---- | 28.91%747.17M | ---- | 215.85%579.62M |
| prepayments (increase)decrease | ---- | 187.74%5.07M | ---- | -69.61%-5.78M | ---- | 13.12%-3.41M | ---- | -222.17%-3.92M | ---- | 87.52%-1.22M |
| Special items for working capital changes | ---- | -113.00%-151.03M | ---- | 182.49%1.16B | ---- | -59.39%411.15M | ---- | 1,813.68%1.01B | ---- | -145.90%-59.08M |
| Cash from business operations | ---- | -11.05%5.45B | ---- | 62.05%6.13B | ---- | 91.41%3.78B | ---- | 53.61%1.98B | ---- | 58.05%1.29B |
| Other taxs | ---- | -33.61%-782.53M | ---- | -67.34%-585.66M | ---- | -271.39%-349.99M | ---- | -20.82%-94.24M | ---- | -49.71%-78M |
| Special items of business | -52.65%1.3B | ---- | 88.63%2.75B | ---- | 82.70%1.46B | ---- | 85.33%798.01M | ---- | 94.07%430.59M | ---- |
| Net cash from operations | -52.65%1.3B | -15.77%4.67B | 88.63%2.75B | 61.51%5.54B | 82.70%1.46B | 82.39%3.43B | 85.33%798.01M | 55.72%1.88B | 94.07%430.59M | 58.62%1.21B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 159.52%191.48M | 93.29%217.63M | 62.53%73.78M | 65.60%112.59M | 186.74%45.4M | -13.53%67.99M | -46.49%15.83M | 46.66%78.64M | -8.56%29.59M | -32.77%53.62M |
| Dividend received - investment | ---- | ---- | ---- | --8.32M | --8.32M | ---- | ---- | ---- | ---- | ---- |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | 200.00%50M | --50M | ---50M | ---- | ---- |
| Decrease in deposits (increase) | -94.09%2.59M | -102.61%-27.84M | -94.71%43.82M | 166.90%1.07B | 224.90%827.85M | 126.80%400.3M | -5.02%-662.81M | -267.47%-1.49B | -8.69%-631.15M | -145.87%-406.44M |
| Sale of fixed assets | 7.15%15.2M | 878.16%196.86M | 73.59%14.18M | -75.11%20.13M | -88.86%8.17M | 21.62%80.86M | 107.85%73.35M | 39.54%66.49M | 1,764,300.00%35.29M | 8,889.62%47.65M |
| Purchase of fixed assets | 21.58%-1.87B | 31.06%-4.05B | 11.30%-2.38B | 9.83%-5.87B | 34.09%-2.68B | -8.02%-6.51B | -39.82%-4.07B | -87.65%-6.02B | -286.51%-2.91B | -139.49%-3.21B |
| Purchase of intangible assets | ---- | ---184.94M | ---173.5M | ---- | ---- | ---15.31M | ---- | ---- | ---- | 92.78%-24.07M |
| Acquisition of subsidiaries | ---- | ---- | ---- | 87.11%-281.04M | ---- | -38,263.90%-2.18B | ---2.03B | 98.11%-5.68M | ---- | ---300.82M |
| Recovery of cash from investments | -67.69%3.47B | 68.34%15.04B | 161.07%10.75B | -84.32%8.94B | -90.02%4.12B | 213.57%56.98B | 370.42%41.27B | 387.26%18.17B | 239.66%8.77B | 173.26%3.73B |
| Cash on investment | 77.41%-2.24B | -43.30%-14.47B | -117.33%-9.92B | 82.74%-10.1B | 89.24%-4.56B | -248.44%-58.51B | -354.03%-42.4B | -466.19%-16.79B | -243.03%-9.34B | -161.55%-2.97B |
| Other items in the investment business | 2,307.12%42.61M | -77.52%43.68M | 101.45%1.77M | 501.63%194.34M | -805.14%-122.3M | 102.77%32.3M | 13.81%17.34M | 17.62%-1.17B | -46.51%15.24M | -2,440.27%-1.42B |
| Net cash from investment operations | 75.93%-382.53M | 45.36%-3.23B | 32.74%-1.59B | 38.47%-5.91B | 69.48%-2.36B | -33.06%-9.6B | -92.04%-7.74B | -60.58%-7.22B | -178.54%-4.03B | -980.08%-4.49B |
| Net cash before financing | -20.79%919.59M | 492.67%1.44B | 228.30%1.16B | 94.06%-366.58M | 86.97%-904.87M | -15.66%-6.17B | -92.85%-6.94B | -62.36%-5.34B | -193.84%-3.6B | -1,050.95%-3.29B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -52.91%366.74M | -54.07%1.1B | 88.17%778.72M | 253.81%2.39B | -36.36%413.84M | -42.34%675.28M | -44.42%650.29M | -42.86%1.17B | --1.17B | --2.05B |
| Refund | 57.72%-358.43M | 29.69%-1.8B | -119.37%-847.73M | -251.95%-2.56B | -36.05%-386.44M | -142.13%-728.27M | -99.61%-284.05M | -114.84%-300.78M | ---142.3M | ---140M |
| Issuing shares | -15.84%10.95M | 9,933.50%3.63B | -32.21%13.01M | -99.67%36.18M | -99.83%19.19M | 95.35%11.04B | 29,015.89%11.01B | 57.07%5.65B | 99.37%37.81M | 11.50%3.6B |
| Interest paid - financing | 8.95%-99.52M | -100.74%-217.28M | -148.91%-109.3M | -30.09%-108.24M | -5.56%-43.91M | -0.79%-83.2M | -16.53%-41.6M | -65.75%-82.54M | -525.39%-35.7M | ---49.8M |
| Absorb investment income | ---- | -50.12%289.3M | -93.92%30.91M | --579.94M | --508.41M | ---- | ---- | --216.89M | --37.92M | ---- |
| Issuance expenses and redemption of securities expenses | ---1.24B | 67.11%-922.52M | ---- | -8.04%-2.8B | -777.99%-691.06M | -6,562.96%-2.6B | -27,420.63%-78.71M | -82.11%-38.96M | -11.28%-286K | -11.21%-21.39M |
| Other items of the financing business | ---80.93M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | -684.70%-1.48B | 175.67%1.96B | 14.11%-188.04M | -131.57%-2.59B | -101.95%-218.94M | 25.04%8.21B | 973.84%11.22B | 21.30%6.57B | 25,085.36%1.04B | 68.79%5.41B |
| Effect of rate | 406.05%39.68M | -135.99%-125.99M | -105.07%-12.97M | 366.24%350.11M | 396.91%255.82M | 61.37%-131.5M | -242.11%-86.16M | -5,697.96%-340.4M | 4,607.30%60.63M | -120.85%-5.87M |
| Net Cash | -157.15%-555.99M | 214.96%3.4B | 186.57%972.88M | -245.08%-2.96B | -126.31%-1.12B | 65.69%2.04B | 267.14%4.27B | -42.14%1.23B | -109.31%-2.56B | -40.13%2.13B |
| Begining period cash | 51.20%9.67B | -28.97%6.4B | -28.97%6.4B | 26.88%9B | 26.88%9B | 14.35%7.1B | 14.35%7.1B | 51.93%6.21B | 51.93%6.21B | 710.59%4.08B |
| Cash at the end | 24.45%9.15B | 51.20%9.67B | -9.59%7.36B | -28.97%6.4B | -27.89%8.14B | 26.88%9B | 204.08%11.28B | 14.35%7.1B | 29.52%3.71B | 51.93%6.21B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data